Clinical Trials
4 trialsNCT02085798 2020-01-27
Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)
Celgene
Completed
NCT02164071 2019-11-18
GAH
Celgene
Completed
NCT02891551 2019-07-24
OCEAN
Celgene
Completed
NCT02461316 2016-11-02
Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia
Hoffmann-La Roche
Completed